Sign Up to like & get
recommendations!
0
Published in 2019 at "Behavioural Pharmacology"
DOI: 10.1097/fbp.0000000000000494
Abstract: Evidence of changes in central noradrenergic activity has been reported in schizophrenic patients and studies indicate that activation of the α2-adrenoceptor improves memory and neuroprotection. In this study, a new imidazolidine derivative 3-(2-chloro-6-fluorobenzyl)-imidazolidine-2,4-dione, PT-31, a…
read more here.
Keywords:
cognitive symptoms;
memory;
putative adrenoceptor;
adrenoceptor ... See more keywords